Thursday, Jul 30, 2026
English News
  • Hyderabad
  • Telangana
  • AP News
  • India
  • World
  • Entertainment
  • Sport
  • Science and Tech
  • Business
  • Rewind
  • ...
    • NRI
    • View Point
    • cartoon
    • My Space
    • Education Today
    • Reviews
    • Property
    • Lifestyle
E-Paper
  • NRI
  • View Point
  • cartoon
  • My Space
  • Reviews
  • Education Today
  • Property
  • Lifestyle
Home | Business | Natco Pharma Board Okays Acquiring 1 In Canadian Arm

Natco Pharma board okays acquiring 1% in Canadian arm

Stocks of Natco Pharma were trading 0.74 per cent lower at Rs 810.85 apiece on BSE. 

By PTI
Published Date - 26 March 2021, 05:56 PM
Natco Pharma board okays acquiring 1% in Canadian arm
whatsapp facebook twitter telegram

New Delhi: Drug major Natco Pharma on Friday said its board has approved acquiring about 1 per cent stake in its Canadian subsidiary.

The company, however, did not disclose the value of the deal. “The board of directors of the company at their meeting approved to acquire 0.96 per cent stake in Natco Pharma (Canada) Inc., after this acquisition Natco Pharma (Canada) Inc., (will) become a wholly owned subsidiary company of Natco Pharma Ltd,” Hyderabad-based Natco Pharma said in a regulatory filing.


The company did not share any more details. Stocks of Natco Pharma were trading 0.74 per cent lower at Rs 810.85 apiece on BSE.

  • Follow Us :
  • Tags
  • Canadian subsidiary
  • Hyderabad-based Natco Pharma
  • Natco Pharma
  • regulatory filing

Related News

  • Hyderabad-based Natco Pharma, Hetero Labs, Dr Reddy’s arm bag generic drug contracts in China

    Hyderabad-based Natco Pharma, Hetero Labs, Dr Reddy’s arm bag generic drug contracts in China

  • Hyderabad-based Natco Pharma offers to acquire nearly 36 per cent stake in Adcock Ingram in Rs 2,100-crore deal

    Hyderabad-based Natco Pharma offers to acquire nearly 36 per cent stake in Adcock Ingram in Rs 2,100-crore deal

  • Hyderabad-based Natco Pharma shares crash 19 per cent on poor financial results

    Hyderabad-based Natco Pharma shares crash 19 per cent on poor financial results

  • Hyderabad-based Natco Pharma gets FDA approval for marketing Bosentan Tablets in the United States

    Hyderabad-based Natco Pharma gets FDA approval for marketing Bosentan Tablets in the United States

Latest News

  • AIMIM leader regrets supporting Congress in Zaheerabad municipal elections, slaps self with slipper

    43 mins ago
  • Hyderabad’s Teja Kalvakota gears up for lead role in Telugu web series ‘Azadi 501’

    15 mins ago
  • CWG 2026: Seema Kaliramna says motherhood transformed her as an athlete

    1 hour ago
  • Telangana artist Hothi Basavaraj showcases 30 years of Basava-inspired sculptures

    1 hour ago
  • Siddharth: ‘Operation Safed Sagar’ is about human relationships, not just war

    1 hour ago
  • Waterlogging, infrastructure works trigger massive traffic jams across Hyderabad

    1 hour ago
  • BCCI hails Ajinkya Rahane’s remarkable career, says his legacy goes beyond numbers

    1 hour ago
  • Hyderabad roads turn hazardous as heavy rains leave potholes, damaged stretches

    1 hour ago

company

  • Home
  • About Us
  • Contact Us
  • Privacy Policy

business

  • Subscribe

telangana today

  • Telangana
  • Hyderabad
  • Latest News
  • Entertainment
  • World
  • Andhra Pradesh
  • Science & Tech
  • Sport

follow us

  • Telangana Today Telangana Today
Telangana Today Telangana Today

© Copyrights 2024 TELANGANA PUBLICATIONS PVT. LTD. All rights reserved. Powered by Veegam